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Monday, February 22, 2010 357acTnI63-193 found following severe ischemic/reperfusion affects cardiac function
predominantly via decreased myofilament Ca2þ-sensitivity. Our results may
benefit rational drug development aimed to prevent ischemic/reperfusion injury
in patients.
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Muscle contraction is regulated by the troponin complex which is a heterotrimer
protein consisting of a Ca2þ binding subunit (TnC), an inhibitory subunit (TnI)
and a Tropomyosin binding subunit (TnT). Calcium binding to TnC (‘ON’
state) initiates a series of structural changes in the thin filament proteins leading
to muscle contraction. In the low Ca2þ ‘OFF’ state, the TnI subunit induces
muscle inhibition through its two actin binding domains (residues 133-148
and 166-210). Another region of TnI termed the ‘switch peptide’ (residues
150-161) is essential for a complete relieve of muscle inhibition in the ON state.
The position of the switch peptide is vital since it affects the whereabouts of
both TnI actin binding domains. In theþCa2þ cardiac Tn core crystal structure,
the switch peptide is depicted to be close to the N-lobe of TnC (Takeda et al.,
Nature, 2003) but no or limited knowledge is known about its position in the
absence of Ca2þ. We studied the proximity of the switch peptide to two do-
mains within Tn in both the ‘ON’ and ‘OFF’ states. Two intermolecular dis-
tances from each end of the switch peptide back to the N-lobe of TnC
(TnI152/TnC35, TnI152/TnC84, TnI160/TnC55) and one intramolecular dis-
tance (TnI129/TnI160) within TnI were measured with Conventional Electron
Paramagnetic Resonance (cw) and Double Electron Electron Resonance
(DEER) methods. In the ‘ON’ state, both the intramolecular and intermolecular
distances were less than 2.5nm with narrow distance distributions indicative of
restricted movement. Upon removal of Ca2þ, distances increased considerably
(TnI129/160 to 5nm and TnI151/TnC35 to 3.3nm) with an accompanying in-
crease in the distance distributions suggesting a more flexible, non-bound,
switch peptide.
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Ca2þ regulation of cardiac muscle contraction is dependent upon regulation by
tropomyosin (Tm) and troponin (Tn); the extreme C-terminus of the inhibitory
subunit of Troponin (cTnI) binds to actin at low [Ca2þ] and is presumed to hold
Tm in a closed position preventing actomyosin interaction. cTnI’s C terminus
(‘‘mobile domain’’ (MD)) is the site of several human mutations that lead to
familial hypertrophic cardiomyopathy (FHC), therefore it is of interest to clar-
ify the specific function and importance of this domain in cardiac muscle con-
traction. We have demonstrated that even in the absence of Tm, Tn is able to
enhance thin filament sliding speed and heavy meromyosin ATPase activity.
To explore the possibility that theMDplays a role in enhancement of myosin ac-
tivity in cardiac muscle, we have utilized an all-cardiac protein (porcine cardiac
actin andmyosin, recombinant human cardiac Tm-Tn) In VitroMotility assay to
detect alterations in Ca2þ regulation of cardiac actomyosin interaction in the
presence of two specific human recombinant cTn MD structural mutants.
‘‘K164D’’ is truncated after cTnIK164and ‘‘LINK2c2’’ has an inserted8-amino
acid linker before cTnI K164. At pCa5, K164D showed no significant difference
from WT in filament sliding speed at most Tn-Tm concentrations tested, while
sliding speed with LINK 2c2 was significantly slower than WT. Conversely,
at pCa9, K164D was unable to stop actomyosin interaction, with sliding speeds
significantly faster than WT; LINK 2c2 regulated the same as WT at pCa9 for
most concentrations tested. Our in vitro cardiac muscle experimental data sug-
gest that (1) the MD of TnI is a key player in Ca2þ regulation of cardiac muscle
contraction, and (2) the C-terminalMobileDomain of cTnI is not responsible for
observed functional enhancement of myosin at saturating [Ca2þ].
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Troponin I plays an essential role in the regulation of cardiac muscle contrac-
tion. Together with troponin C and T, troponin I induces Ca2þ dependent co-
operative transitions of thin filaments between a blocked, a closed and an
open state. 29 mutations were found in cardiac troponin I in families withhypertrophic cardiomyopathy. Although unknown, the mechanism of molecu-
lar dysfunction is likely to involve an aberrant thin filament responsiveness to
changes in intracellular level of Ca2þ. Our hypothesis is that these mutations
modify important parameters in the cooperative-allosteric transitions of thin fil-
aments. Here we aimed at using transient kinetics to assess the effect of hyper-
trophic cardiomyopathy TnI mutations (Q130R, R145G, and A157V) on the
rate and equilibria of thin filament switching between the blocked, closed
and open states. We found that TnIQ130R and TnIA157V did not affect the
equilibrium constant between the blocked and the closed states (KB). In con-
trast TnIR145G substantially increased KB in the absence of Ca
2þ. An increase
in KB is likely to lead to incomplete relaxation. We also investigated the effect
of these mutations on the cooperative behaviour of thin filaments. TnIQ130R
and A157V did not affect the size of the cooperative unit n while TnIR145G
decrease n value to less than 7. Calcium binding to thin filaments was moni-
tored by change in the fluorescence of IAANS-TnCC84S. Thin filaments recon-
stituted with TnI mutations showed a change in calcium affinity and the rate of
Ca2þ dissociation. These findings suggest that mutations in different regions of
troponin I are likely to have different biochemical effect highlighting the
unique molecular mechanism for each of these mutations.
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Cardiac TnI (cTnI) has a unique N-terminal extension containing the PKA
phosphorylation sites, and its removal by restricted proteolysis in cardiac adap-
tations to hemodynamic stress and b-adrenergic deficiency provides a func-
tional compensation via improving myocardial relaxation (Barbato et al.,
JBC 2005; Feng et al., JBC 2008). By transgenic expression of N-terminal trun-
cated cTnI (cTnI-ND) in the cardiac muscle of cTnI knockout mice, we exam-
ined the function of hearts containing purely cTnI-ND. Working hearts from
the double transgenic mice showed no hypertrophy and normal baseline func-
tion as compared with the wild type controls, confirming the non-destructive
nature of cTnI-ND. When preload was raised to examine the Frank-Starling re-
sponse, left ventricular relaxation velocity was better maintained in cTnI-ND
hearts than that in wild type controls. The effect of cTnI-ND on enhancing re-
laxation resulted in lower left ventricular end diastolic pressure and maintained
left ventricular contractile velocity and end systolic pressure, especially at high
preloads. The overall outcome was larger stroke volumes from cTnI-ND hearts
at increased preloads than the responses of wild type hearts. The enhanced
range and extent of positive response of cTnI-ND hearts to preload demon-
strates that the removal of cTnI N-terminal extension by restricted proteolysis
provides a novel mechanism to maximize the Frank-Starling effect in cardiac
adaptation against hemodynamic and inotropic stresses.
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Mutations in cardiac troponin, a protein complex that regulates muscle contrac-
tion, have been shown to be linked to cardiomyopathies, which commonly lead
to chest pains, myocardial infarction, or sudden cardiac death. The troponin
complex consists of three proteins: Troponin T, Troponin I (TnI), and Troponin
C (TnC). In recent clinical studies, two novel mutations in cardiac TnI were dis-
covered co-segregated with cardiomyopathy, but their specific functional ef-
fects remain unknown. These mutations are the first frameshift mutations in
cTnI known to be linked to restrictive cardiomyopathy (RCM). The deletion
of two adenines at codon 177 (Delbp529AA) in cardiac TnI, was discovered
in a six year old female RCM patient. The second cTnI mutation included in
this investigation was the result of a deleted guanine in codon 168 which caused
a frame shift and premature stop codon at 176 (DelG502). cTnI DelG502 was
associated with sudden cardiac death. It was found during column purification
that the 34 residue truncation of cTnI removed or greatly decreased its binding
affinity for TnC. However, the Delbp529AA mutant protein, containing 32 al-
ternate C-terminal residues, was successfully purified and formed a functional
troponin complex. Actomyosin ATPase assays demonstrated similar maximal
ATPase activity for complexes containing TNNI3 Delbp529AA compared to
wild type complexes. cTnI Delbp529AA showed increased calcium sensitivity
of ATPase and less inhibitory function compared to wild-type cTnI. Calpain
358a Monday, February 22, 2010digestion studies indicate that cTnI Delbp529AA is degraded at a faster rate
than wild-type cTnI. These results suggest that the poor prognosis of patients
carrying these RCM-linked mutants is due to protein dysfunction at multiple
levels and suggest possible mechanisms of RCM pathology.1851-Pos
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Protein kinase C (PKC) isoforms have been shown to play an important role in
the development of heart failure. Most research performed on PKCa has been
done in rodents and direct evidence in human heart failure is limited. Our pre-
vious study showed a decrease in Ca2þ-sensitivity in failing tissue upon PKCa
treatment of cardiomyocytes via phosphorylation of cardiac troponin I (cTnI),
cardiac troponin T (cTnT) and myosin binding protein C (cMyBP-C). This
study aims to determine the targets of PKCa on cTnI and cTnT. Western im-
munoblotting revealed that PKCa is less abundant but more active in failing
compared to donor tissue. PKCa treatment of donor and failing tissue was
able to phosphorylate Thr-143, which is a known PKCa site on cTnI, but en-
dogenous phosphorylation levels were very low. LC-MS analysis of purified
human recombinant cTn complex incubated with PKCa identified two novel
phosphorylation sites, Ser-199 located on cTnI and Ser-189 on cTnT. Both sites
are located in conserved regions on cTnI and cTnT. The PKA sites Ser23/24 on
cTnI are phosphorylated by PKCa in purified human recombinant cTn com-
plex, but there is no cross phosphorylation in donor and failing tissue. In con-
clusion, endogenous Thr-143 phosphorylation is low, which makes its involve-
ment in heart failure unlikely. Exogenous PKCa phosphorylation of Thr-143
and Ser-199 on cTnI and Ser-189 on cTnT could possibly explain the decrease
in Ca2þ-sensitivity observed and further research on the site-specific effects is
warranted.1852-Pos
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Troponin T (TnT) and troponin I (TnI) are two subunits of the troponin com-
plex. We previously found a single amino acid substitution in the TnT-binding
helix of cardiac TnI (cTnI) in wild turkey hearts that expressed abnormally
spliced myopathic cardiac TnT (cTnT) (Biesiadecki et al., JBC 279:13825-
32, 2004). To test the potential role of this cTnI modification in rescuing
a cTnT abnormality, we developed transgenic mice expressing the cTnI var-
iant (K118C) with or without a deletion of endogenous cTnI gene to mimic
homozygote and heterozygote wild turkeys. Double and triple transgenic
mice were created to combine the cTnI-K118C allele with an allele encoding
the abnormally spliced cTnT (exon 7 deletion). Functional analysis in ex vivo
working hearts found that cTnI-K118C had no destructive effect on cardiac
muscle and baseline heart function but was able to rescue the decreases in car-
diac function caused by cTnT exon 7 deletion. Further characterizations
showed that cTnI-K118C significantly blunted the inotropic response of car-
diac muscle to b-adrenergic stimulation whereas the PKA-dependent phos-
phorylation of cTnI was unchanged. These data indicate that TnI-TnT interac-
tion is a critical link in Ca2þ signaling and b-adrenergic regulation of
myocardial contraction, providing a novel target for the treatment of heart
failure.
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An alpha-helical region of cardiac troponin T, cH2(T), is centrally positioned
in the core domain of the troponin complex (Takeda et al., Nature 2003
vol.424(6944):p35-41). cH2(T)-troponin I and cH2(T)-troponin C interactions
have been illustrated through biochemical studies and visualized in the crystal
structure of the core domain of human cardiac troponin, suggesting an impor-tant regulatory role for cH2(T). However, little is known about how the car-
diac-specific structure of cH2(T) relates to cardiac-specific contractile func-
tion. To better understand the functional significance of cH2(T), we created
a chimeric rat cardiac troponin T (TnT) in which cH2(T) was replaced by
the corresponding helical region of rat slow skeletal TnT and studied how re-
placement of native TnT with chimeric TnT affected contractile function of
rat cardiac muscle. We measured isometric force, ATPase activity, and
length-dependent contractile dynamics in detergent skinned papillary muscle
bundles reconstituted with either wild-type or chimeric TnT, held at either sar-
comere length (SL) 2.0 mm or 2.2 mm. Preliminary studies suggest that the SL
dependence of Ca2þ-activated maximal force production and tension cost was
depressed in bundles containing chimeric TnT. For example, bundles contain-
ing the chimeric TnT showed an 8.4% decrease in force production when SL
was decreased from 2.2 mm to 2.0 mm, whereas bundles containing the wild-
type TnT showed a 43.9% decrease in force production. In addition, length-
dependent contractile dynamics were significantly altered in bundles contain-
ing the chimeric TnT. For example, the length-dependent rate constant of
crossbridge recruitment was slower, and the rate constant of crossbridge de-
tachment was faster in bundles containing the chimeric TnT. Thus, our data
suggest that cH2(T) plays a role in cardiac-specific length-mediated myofila-
ment activation, an important mechanism underlying the Frank-Starling rela-
tionship.
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Familial Hypertrophic Cardiomyopathy (FHC) is a primary cardiac muscle
disorder and a common cause of sudden cardiac death among young people
in the field. The majority of disease-causing mutations in the thin filament
protein hcTnT are found within the TNT1 domain. This domain has not
been crystallized and its structural details are poorly defined, limiting our
ability to understand the mechanism of disease for these mutations. A highly
charged region is found at the C-terminal end of TNT1
(158-RREEEENRR-166) in which this highly alpha helical domain may un-
wind to create a flexible hinge that is necessary for normal function. We
aim to determine the structural details and function of this region using
SDSL-EPR and regulated in vitro motility (R-IVM) assays. The purpose of
our R-IVM experiments is two-fold: to functionally analyze our spin labeled
proteins and to gain insight into the function of TNT1 in the presence of cys-
teine substitutions. R-IVM data shows a progressive increase in the severity of
the functional effects of cysteine substitution and spin labeling across the pu-
tative hinge region, suggesting that this region is dynamically important and
may be making critical interactions with other components of the sarcomere.
CW-EPR spectra of spin labeled hcTnT in Troponin ternary complexes show
an increase in spin label mobility from residue 153 to 157 and 177, consistent
with a decrease in alpha helical character across the putative hinge region.
Preliminary doubly labeled CW-EPR experiments show that interspin distance
between hcTnT residues 157 and 177 exceed 25A. Interspin distance measure-
ments using doubly labeled hcTnT will further elucidate the secondary and
tertiary structure of this region. Additional spin label pairs are currently being
investigated using both CW-EPR and DEER techniques to determine the
structural details of this important region.
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Tropomyosin-kappa (TPM1k), a novel TM isoform, is exclusively expressed
in the human heart. Alternative splicing of the a-TM gene generates TPM1k,
in which the skeletal muscle exon 2b is replaced by the smooth muscle exon
2a. We previously reported that TPM1k expression was increased in the
hearts of patients with chronic dilated cardiomyopathy (DCM). To under-
stand how the TPM1k isoform affects cardiac dynamics, we generated trans-
genic (TG) mice expressing TPM1k in the myocardium. Most of the native
TM (90%) is replaced by TPM1k. In situ cardiac dynamics were determined
by echocardiographic analysis. Results demonstrated that the TG hearts ex-
hibited a diastolic dysfunction associated with a dilation of the left ventricle
compared with the non transgenic (NTG) controls. We also compared force-
pCa relations in detergent extracted (skinned) fiber bundles isolated from
NTG and TG-TPM1k hearts at sarcomere lengths (SL) 1.9 mm and 2.3mm.
Our data demonstrated a significant decrease in the Ca2þ sensitivity of the
